Greenlight Capital Re reported a net income of $3.2 million for Q3 2026, rebounding from a loss the previous year, driven by strong underwriting results with a 90.5% combined ratio. Gross premiums written slightly declined by 1%, while the company repurchased $8 million of its shares during the quarter, boosting fully diluted book value per share by 0.8% to $20.78. Despite a challenging investment environment, the firm's conservative reserving and underwriting discipline helped maintain profitability. The company plans to discuss these results further in an upcoming earnings call.
Greenlight Capital Re's Q3 2026 financial results provide context for readers, with Pluang's snapshot as of Nov 03, 2026 03:21 WIB showing 113 of 142 Financials-sector US stocks rose while 29 fell. Notable movers include HUT at USD 55.36 with a 6.80% decline and 100% sell order activity, UPST at USD 21.52 down 6.52% but with 100% buy order activity, and CLSK at USD 7.22 down 5.68% with 100% buy order activity. The most notable figure is the 113 rising stocks out of 142 in the sector.
The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...
Exosens disclosed its monthly update on the total number of shares and voting rights in its share capital as of October 31, 2026. The company has 50,936,749 shares outstanding, with 59,162,039 exercisable voting rights after deducting treasury shares...
Exosens has released its monthly update on the total number of shares and voting rights composing its capital as of October 31, 2026. The company reports 50,936,749 total shares and 59,425,768 theoretical voting rights, with 59,162,039 exercisable vo...
Recursion Pharmaceuticals announced positive Phase 2 results for REC-4881, an oral MEK1/2 inhibitor, in treating familial adenomatous polyposis (FAP). The TUPELO trial showed a 47% median reduction in total polyp burden after 12 weeks of treatment, w...
Vornado Realty Trust reported a net loss of $47.1 million for Q3 2026, a decline from net income of $11.6 million in the prior year period, primarily due to a large gain in 2025 related to a master lease. However, funds from operations (FFO) increase...
